CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS - Concepedia

Concepedia

Publication | Open Access

CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS

DOI Full Paper Access

46

Citations

21

References

2020

Year

Giovanna Capodivento, Chiara De Michelis, M. Carpo, Roberto Fancellu, Erika Schirinzi, Daniele Severi, Davide Visigalli, Diego Franciotta, Fiore Manganelli, Gabriele Siciliano,

Journal of Neurology Neurosurgery & Psychiatry

Abstract

CSF SM is a diagnostic and staging wet biomarker for acquired demyelinating neuropathies and may effectively improve the management of patients affected by GBS and CIDP.

References

	Year	Citations

Page 1